Evaluation of the Visby medical COVID-19 point of care nucleic acid amplification test
- 17 November 2021
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 117, 1-3
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Evaluation of the Cue Health point-of-care COVID-19 (SARS-CoV-2 nucleic acid amplification) test at a community drive through collection centerDiagnostic Microbiology and Infectious Disease, 2021
- Analytical Evaluation of Visby Medical RT-PCR Portable Device for Rapid Detection of SARS-CoV-2Diagnostics, 2021
- Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal SpecimensJournal of Clinical Microbiology, 2020
- Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2Journal of Clinical Microbiology, 2020
- SARS-CoV2 Testing: The Limit of Detection MattersbioRxiv, 2020
- The Measurement of Observer Agreement for Categorical DataBiometrics, 1977